Max Reinhardt

Max Reinhardt

President at
Pacira Pharmaceuticals, Inc. (California)

Net worth: 54 209 $ as of 30/06/2026

55 year
Health Technology
Consumer Services
Distribution Services

Profile

Max Reinhardt is currently President at Pacira Pharmaceuticals, Inc. (California).
Former positions include President-Global Spine Business at Orthofix Medical, Inc. from 2024 to 2026, President at Pacira Biosciences, Inc. from 2019 to 2020, Worldwide President at DePuy Synthes Sales, Inc. from 2012 to 2019, Worldwide President-DePuy Synthes Spine at Johnson & Johnson from 2012 to 2015, and Manager-National Sales at STERIS Corp.
from 2001 to 2002.
Education includes graduate studies at The University of Hull.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/04/2026 5,931 ( 0.01% ) 54 209 $ 30/06/2026

Max Reinhardt active positions

CompaniesPositionStart
President -

Former positions of Max Reinhardt

CompaniesPositionEnd
ORTHOFIX MEDICAL INC. Corporate Officer/Principal 12/06/2026
Corporate Officer/Principal 01/05/2019
JOHNSON & JOHNSON Corporate Officer/Principal 01/01/2015
STERIS CORP Sales & Marketing 01/01/2002
PACIRA BIOSCIENCES, INC. President 09/06/2020
See the detail of Max Reinhardt's experience

Training of Max Reinhardt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

35

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Distribution Services